The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Transforming biomedical innovations into therapies
Venture capitalvidaventures.comSince 2026-10-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Soufflé Therapeutics, Inc. A leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives | Series B Verified against 1 of 3 sources | $135M | 2026-10-13 | [ PART ] |